PredxBio
PredxBio turns tumor biopsy images into spatially informed biomarkers that guide immunotherapy decisions and accelerate drug development. The company applies spatial analytics, explainable AI, and machine learning to whole-slide H&E and immunohistochemistry images, integrating microdomain biology and tissue-based multi-omics to identify cell types, functional states, and intercellular interactions. PredxBio offers a B2B computational pathology platform and tools for tissue QC, biomarker discovery, patient stratification, and translational deployment for pharmaceutical companies, translational researchers, and clinical laboratories. The platform is designed to support clinical trial design and companion diagnostic development to advance precision oncology.
PredxBio
PredxBio turns tumor biopsy images into spatially informed biomarkers that guide immunotherapy decisions and accelerate drug development. The company applies spatial analytics, explainable AI, and machine learning to whole-slide H&E and immunohistochemistry images, integrating microdomain biology and tissue-based multi-omics to identify cell types, functional states, and intercellular interactions. PredxBio offers a B2B computational pathology platform and tools for tissue QC, biomarker discovery, patient stratification, and translational deployment for pharmaceutical companies, translational researchers, and clinical laboratories. The platform is designed to support clinical trial design and companion diagnostic development to advance precision oncology.
TL;DR
Founded: 2017
Headquarters: Pittsburgh, Pennsylvania
Product: SpaceIQ decision-intelligence platform for spatial tissue and multi-omic analytics
Customers: Pharmaceutical companies, translational researchers, clinical laboratories (B2B)
Recent funding activity: Multiple seed rounds with investors including Innovation Works and K4 Forum Mumbai Network
Company Overview
Problem Domain
Computational pathology and spatial biology for drug development and precision oncology
Founded
2017
Industry
Biotechnology
Funding Track Record
Crunchbase lists this round as closed Jun 20, 2024 and names Innovation Works and K4 Forum Mumbai Network as investors
Investor Signal
“Innovation Works; K4 Forum Mumbai Network”